OREX - Orexigen Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $6.57. This is a potential upside of $6.57 (0%) from yesterday's end of day stock price of $0.

Orexigen Therapeutics's activity chart (see below) currently has 16 price targets and 12 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 11.11% with an average time for these price targets to be met of 28 days.

Most recent stock forecast was given by CHARLES DUNCAN from CANTOR FITZGERALD on 16-Mar-2016. First documented stock forecast 17-Oct-2014.

Best performing analysts who are covering OREX - Orexigen Therapeutics:

Charles Duncan Simos Simeonidis Paul Matteis

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

20

$19.78 (8990.91%)

8 years 1 months 22 days ago

0/6 (0%)

$14.7 (277.36%)

Hold

6

$5.78 (2627.27%)

10

8 years 1 months 22 days ago

1/3 (33.33%)

$0.7 (13.21%)

84

Hold

20

$19.78 (8990.91%)

110

8 years 2 months 15 days ago

0/3 (0%)

$4.3 (27.39%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is OREX (Orexigen Therapeutics) average time for price targets to be met?

On average it took 28 days on average for the stock forecasts to be realized with a an average price target met ratio 11.11

Which analyst has the current highest performing score on OREX (Orexigen Therapeutics) with a proven track record?

CHARLES DUNCAN

Which analyst has the current lower performing score on OREX (Orexigen Therapeutics) with a proven track record?

PAUL MATTEIS

Which analyst has the most public recommendations on OREX (Orexigen Therapeutics)?

Charles Duncan works at CANTOR FITZGERALD and has 2 price targets and 2 ratings on OREX

Which analyst is the currently most bullish on OREX (Orexigen Therapeutics)?

Paul Matteis with highest potential upside - $19.78

Which analyst is the currently most reserved on OREX (Orexigen Therapeutics)?

Simos Simeonidis with lowest potential downside - $5.78

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?